期刊文献+

不同培养基中CIK的生物学特性及其对肿瘤细胞的杀伤效果

Research on Biological Characteristics and Cytotoxicity of CIK Cells in Different Culture Systems
下载PDF
导出
摘要 目的比较健康人和肿瘤患者细胞因子诱导的杀伤细胞(cytokine-induced killer,CIK)在淋巴细胞无血清培养基及普通无血清培养基中的细胞形态、体外扩增速度、细胞表型及其对肿瘤细胞株的杀伤活性。方法取健康人和肿瘤患者外周血各3例,经密度梯度离心获得外周血单个核细胞(PBMC),分别在淋巴细胞无血清培养基及普通无血清培养基中,加入基因重组人干扰素γ(rhIFN-γ)、抗人CD3单克隆抗体(OKT3)和基因重组人白细胞介素2(rhIL-2),体外诱导CIK细胞,比较细胞的形态、扩增速度、细胞表型及杀伤活性。结果在不同培养基中健康人外周血CIK细胞的扩增速度、流式细胞学检测的CD3+CD8+和CD3+CD56+细胞百分比以及对K562和HL-60肿瘤细胞株的杀伤活性均显著高于肿瘤患者,差异有统计学意义(P<0.05);两种来源的PBMC在不同的培养基中经过诱导获得的CIK细胞在增殖速度、流式细胞学分析结果及杀伤活性方面差异亦有统计学意义(P<0.05)。结论在不同的培养基中肿瘤患者的PBMC经诱导培养获得的CIK细胞可有显著差别,为临床进一步提高CIK细胞的治疗效果提供了实验依据。 Objective To observe the changes in morphology,phenotype,proliferation activity and cytotoxicity of cytokine induced killer(CIK) cells which were cultured in lymphocytic serum-free medium or in general purpose serum-free medium and from healthy people or tumor patients,and then to investigate the efficiency of CIK cells in cancer immunotherapy.Methods Peripheral blood mononuclear cells(PBMC) were isolated by density gradient centrifugation derived from three healthy subjects and three tumor patients,CIK cells were generated from PBMC in lymphocytic serum-free medium A or B and were incubated in vitro in the presence of IFN-γ followed by OKT3 and IL-2.Proliferation,Morphology,phenotypes,and the cytotoxicity activity were compared.Results The proliferation speed,the percentage of CD3^+CD8^+ and CD3^+CD56^+ cells,as well as the cytotoxicity activity of CIK cells originated from peripheral blood of healthy people were significantly higher than those of tumor patients(P〈0.05) under different culture systems;CIK cells generated from different sources of PBMC also showed significant differences at proliferation speed,phenotypes and cytotoxicity activity when cultured under different systems.Conclusion CIK cells generated from PBMC of tumor patients have significant differences under different culture systems,and provide further experimental basis for improving the clinical curative effect of CIK cells.
出处 《临床误诊误治》 2012年第4期52-55,共4页 Clinical Misdiagnosis & Mistherapy
基金 首都临床特色应用项目(Z111107058811107)
关键词 细胞因子类 培养基 无血清 杀伤细胞 生物医学研究 Cytokine Serum-free culture media Killer cell Biomedical research
  • 相关文献

参考文献11

  • 1Schmidt-Wolf I,Lefterova P,Mehta B,et al.Phenotypiccharacterization and identification of effector cells involvedin tumor cell recognition of cytokine-induced killer cells[J].Experimental hematology,1993,21(13):1673-1679.
  • 2张志凯,祁岩超.健康人和肿瘤患者CIK细胞的生物学特性[J].中国热带医学,2009,9(2):253-254. 被引量:11
  • 3Olioso P,Giancola R,Di-Riti M,et al.Immunotherapywith cytokine induced killer cells in solid and hematopoiet-ic tumours:a pilot clinical trial[J].Hematological oncolo-gy,2009,27(3):130-139.
  • 4要跟东,霍红旗,李鹏,刘爱民.健康人CIK细胞对宫颈癌细胞杀伤作用及其机制的探讨[J].现代妇产科进展,2011,20(3):221-224. 被引量:4
  • 5刘岩青,王悦华.源于健康人与肝癌患者CIK细胞的生物学特性及抗癌活性的研究[J].军医进修学院学报,2008,29(3):214-216. 被引量:2
  • 6Thorne S H,Negrin R S,Contag C H.Synergistic antitu-mor effects of immune cell-viral biotherapy[J].Science,2006,311(5768):1780.
  • 7Linn Y C,Hui K M.Cytokine-induced NK-like T cells:from bench to bedside[J].J Biomed Biotechnol,2010,2010:435745.
  • 8Verneris M R,Ito M,Baker J,et al.Engineering hemato-poietic grafts:purified allogeneic hematopoietic stem cellsplus expanded CD8+NK-T cells in the treatment of lympho-ma[J].Biology of Blood and Marrow Transplantation,2001,7(10):532-542.
  • 9Jiang J,Xu N,Wu C,et al.Treatment of advanced gastriccancer by chemotherapy combined with autologous cytokine-induced killer cells[J].Anticancer Res,2006,26(3):2237-2242.
  • 10Linn Y,Hui K M.Cytokine-induced killer cells:NK-likeT cells with cytotolytic specificity against leukemia[J].Leukemia&lymphoma,2003,44(9):1457-1462.

二级参考文献22

  • 1林丽,陈忠平.细胞因子诱导的杀伤细胞体外抗胶质瘤的实验研究[J].中国神经肿瘤杂志,2003,1(2):69-72. 被引量:8
  • 2赵明,吴沛宏,曾益新,夏建川,张福君,冼励坚,张毓平,周琨,范卫君,张亮,高飞,周启明.经肝动脉栓塞化疗序贯联合射频消融和细胞因子诱导的杀伤细胞治疗肝细胞癌的随机研究[J].中华医学杂志,2006,86(26):1823-1828. 被引量:53
  • 3周启明,吴沛宏,赵明,王其京,黄丽惜,李永强,陈诗萍,夏建川.原发性肝癌经综合微创治疗后联合细胞因子诱导杀伤细胞灌注的近期疗效观察[J].癌症,2006,25(11):1414-1418. 被引量:30
  • 4Schmidt - Wolf IG,Negrin RS,Kiem HP,et al. Use of a SCID mouse/ human lymphoma model to evaluate cytokine induced killer cells with potent antitumor cell activity[J]. J Exp Med, 1991,174(1):139-149.
  • 5Lu PH,Negrin RS. A novel population of expanded humanCD3+ CD56^+cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency[J]. J Immunol, 1994,153(4):1687-1696.
  • 6Jiang J,Xu N,Wu C,et al. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells [ J ]. Anticancer Res, 2006,26(38):2237-2242.
  • 7Linn YC. Hui KM. Cytokine.induced killer cells: NK-like T cells with cytolytic specificity against leukemia[ J]. Leuk Lymphoma, 2003,44: 1457-1462.
  • 8Muller B,Fischer B,Kreutz W.An acidic microenvironment impairs the generation of non-major histocompatibility complex-restricted killer cells[ J ]. Immunol, 2000,99(3) : 375-384.
  • 9Ortaldo JR,Winkler-Pickett RT,Yagita H et al. Comparative studies of CD3-and CD3^+CD56^+cells : examination of morphology ,functions , T cellreceptor rearrangement ,and porefonning protein expression[J]. Cell Immunol , 1991 , 136(2) : 486.
  • 10Schmidt R,Murray C,Daley J,et al.A subset of natural killer cells in peripheral blood displays a mature T cell phenotype[J].Exp Med,1986,164:351-356.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部